Faheem Hasnain
SVP, Oncology SBU, Biogen.
Companies
- Gossamer Bio, Inc.Chief executive officer Mar 1, 2021 to now1
- Gossamer Bio, Inc.President Mar 1, 2021 to now1
- Gossamer Bio, Inc.Board member Sep 27, 2019 to now2
- Kura OncologyBoard member Apr 27, 2015 to now3
- Mirati Therapeutics, Inc.Board member Feb 20, 2019 to Jan 23, 20244
- Nuvation Bio Inc.Board member Jun 30, 2020 to Feb 26, 20215
- Forte Biosciences, Inc.Board member Apr 12, 2017 to Oct 4, 20196
- Gossamer Bio, Inc.Chair Feb 7, 2019 to Mar 26, 20197
- IMMUNIC, INC.Board member Aug 15, 2016 to Sep 17, 20188
- Ambit BiosciencesBoard member May 15, 2013 to Nov 12, 20149
- TercicaBoard member Feb 28, 2008 to Oct 20, 200810
- BiogenSVP, Oncology SBU Feb 8, 2006 to Jul 10, 200811
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Gossamer Bio, Inc. GOSS6,245,866 shares12$53.5M at $8.56Jan 5, 2026
- Kura Oncology KURA23,983 shares13$220.9K at $9.21Dec 9, 2025
- Mirati Therapeutics, Inc.10,791 shares14Jan 23, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 2, 2026Granted 280,000 shares of Gossamer Bio, Inc.12
- Dec 9, 2025Sold 10,000 shares at $10.98 of Kura Oncology13
- Dec 9, 2025Exercised options 10,000 shares at $3.12 of Kura Oncology13
- Oct 1, 2025Granted 437,500 shares of Gossamer Bio, Inc.15
- Mar 21, 2025Sold 22,682 shares at $8.00 of Kura Oncology16
- Mar 21, 2025Exercised options 22,682 shares at $6.32 of Kura Oncology16
- Jun 21, 2024Bought 372,000 shares at $0.67 of Gossamer Bio, Inc.17
- Mar 27, 2024Sold 23,172 shares at $1.16 of Gossamer Bio, Inc.18
- Jan 23, 2024Returned to company 9,702 shares of Mirati Therapeutics, Inc.14
- Jan 23, 2024Returned to company 6,333 shares of Mirati Therapeutics, Inc.14
- Jan 23, 2024Returned to company 8,717 shares of Mirati Therapeutics, Inc.14
- Dec 29, 2023Granted 9,702 shares at $58.75 of Mirati Therapeutics, Inc.19
- Aug 11, 2023Bought 10,791 shares at $27.80 of Mirati Therapeutics, Inc.20
- Jul 24, 2023Granted 540,176 shares at $1.82 of Gossamer Bio, Inc.21
- Mar 22, 2023Bought 440,500 shares at $1.14 of Gossamer Bio, Inc.22
- Mar 21, 2023Bought 269,389 shares at $1.20 of Gossamer Bio, Inc.22
- Mar 20, 2023Bought 168,683 shares at $1.03 of Gossamer Bio, Inc.22
- Jan 20, 2023Granted 6,333 shares of Mirati Therapeutics, Inc.23
- Jul 15, 2022Bought 138,696 shares at $7.21 of Gossamer Bio, Inc.24
- Mar 23, 2022Sold 19,035 shares at $8.92 of Gossamer Bio, Inc.25
- Jan 14, 2022Granted 3,619 shares of Mirati Therapeutics, Inc.26
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARGossamer Bio, Inc., Board member
- 3SEC EDGARKura Oncology, Board member
- 4
- 5SEC EDGARNuvation Bio Inc., Board member
- 6
- 7SEC EDGARGossamer Bio, Inc., Chair
- 8SEC EDGARIMMUNIC, INC., Board member
- 9SEC EDGARAmbit Biosciences, Board member
- 10SEC EDGARTercica, Board member
- 11SEC EDGARBiogen, SVP, Oncology SBU
- 12
- 13
- 14
- 15SEC EDGARForm 4 filed Oct 2, 2025
- 16SEC EDGARForm 4 filed Mar 24, 2025
- 17SEC EDGARForm 4 filed Jun 24, 2024
- 18SEC EDGARForm 4 filed Mar 28, 2024
- 19SEC EDGARForm 4 filed Jan 3, 2024
- 20SEC EDGARForm 4 filed Aug 14, 2023
- 21SEC EDGARForm 4 filed Jul 26, 2023
- 22SEC EDGARForm 4 filed Mar 22, 2023
- 23SEC EDGARForm 4 filed Jan 24, 2023
- 24SEC EDGARForm 4 filed Jul 15, 2022
- 25SEC EDGARForm 4 filed Mar 24, 2022
- 26SEC EDGARForm 4 filed Jan 18, 2022